| human | Q5 |
| P8446 | Gateway to Research person ID | 5100123F-9727-4CE5-9E59-C6F45E04B3A2 |
| P496 | ORCID iD | 0000-0002-4816-8991 |
| P1153 | Scopus author ID | 6603833551 |
| P69 | educated at | University of Edinburgh | Q160302 |
| P108 | employer | University of Oxford | Q34433 |
| University of Edinburgh | Q160302 | ||
| P734 | family name | Whiteley | Q17125773 |
| Whiteley | Q17125773 | ||
| Whiteley | Q17125773 | ||
| P735 | given name | William | Q12344159 |
| William | Q12344159 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q30842993 | 18F-Fluoride and 18F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study |
| Q45929089 | A novel measure of treatment benefit for an ordinal scale: a case study of the IST-1 and the IST-3 stroke trials. |
| Q47252550 | A systematic review of anxiety interventions in stroke and acquired brain injury: Efficacy and trial design |
| Q55139970 | A testing time. |
| Q89997957 | A validated natural language processing algorithm for brain imaging phenotypes from radiology reports in UK electronic health records |
| Q49789139 | Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke |
| Q38417427 | Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial |
| Q57305083 | Alteplase for ischaemic stroke—responses |
| Q64449936 | An Unusual Vascular Cause of Horner’s Syndrome |
| Q48118783 | Anticoagulation Timing for Atrial Fibrillation in Acute Ischemic Stroke: Time to Reopen Pandora's Box? |
| Q50043282 | Anxiety After Stroke: The Importance of Subtyping |
| Q47682102 | Anxiety after stroke: time for an intervention |
| Q112571360 | Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England |
| Q34469067 | Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study |
| Q26861828 | B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis |
| Q55402108 | Baylor neurology case of the month: www.bcm.tmc.edu/neurol/case.html. |
| Q33568328 | Big data and data repurposing - using existing data to answer new questions in vascular dementia research |
| Q37903591 | Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study |
| Q37998544 | Blood biomarkers in stroke: research and clinical practice |
| Q37227913 | Blood biomarkers in the diagnosis of ischemic stroke: a systematic review |
| Q37415033 | Blood markers for the prognosis of ischemic stroke: a systematic review |
| Q57384713 | CSF opening pressure: Reference interval and the effect of body mass index |
| Q57384712 | Cerebral aneurysms |
| Q115119092 | Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study |
| Q64077513 | Clinical diagnosis of TIA or minor stroke and prognosis in patients with neurological symptoms: A rapid access clinic cohort |
| Q64449907 | Clinical diagnosis of TIA or stroke and prognosis in patients with neurological symptoms: a rapid access clinic cohort |
| Q50112922 | Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study |
| Q38751778 | Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis |
| Q30240123 | Cognition in chronic kidney disease: a systematic review and meta-analysis |
| Q34317842 | Comparison of statistical and clinical predictions of functional outcome after ischemic stroke. |
| Q64449931 | Confusion after a game of bridge |
| Q59883114 | Correction: The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England |
| Q34088810 | Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review |
| Q41701562 | Covariate adjustment had similar benefits in small and large randomized controlled trials. |
| Q36078449 | Do acute phase markers explain body temperature and brain temperature after ischemic stroke? |
| Q49789147 | Effect of Dysphagia Screening Strategies on Clinical Outcomes After Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke |
| Q34803882 | Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial). |
| Q26823902 | Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials |
| Q36099907 | Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials |
| Q38401584 | Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke |
| Q47420086 | Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials |
| Q39567529 | Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial |
| Q115012882 | Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial |
| Q33616677 | Formal and informal prediction of recurrent stroke and myocardial infarction after stroke: a systematic review and evaluation of clinical prediction models in a new cohort |
| Q64449933 | Fridtjof Nansen (1861–1930) |
| Q30852035 | Functional status three months after the first ischemic stroke is associated with long-term outcome: data from a community-based cohort |
| Q64446869 | Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV |
| Q64445096 | Hoover's sign for the diagnosis of functional weakness: A prospective unblinded cohort study in patients with suspected stroke |
| Q47211092 | How to do high-quality clinical research 1: First steps |
| Q45908182 | IST-3 stroke trial data available. |
| Q64449927 | Identifying blood biomarkers to improve the diagnosis of stroke |
| Q28255391 | Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis |
| Q30878935 | Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. |
| Q112690210 | Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource |
| Q48431835 | Mortality after thrombolysis - Authors' reply |
| Q24187382 | Parenteral fluid regimens for improving functional outcome in people with acute stroke |
| Q59336205 | Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis |
| Q46407071 | Predicting risks and benefits of treatment with aspirin in the acute stage of ischaemic stroke: an analysis of 3 large randomised controlled trials |
| Q46406624 | Prediction of recurrent stroke and myocardial infarction after stroke: a systematic review of clinical prediction models. |
| Q38236852 | Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis. |
| Q58752487 | Reproducibility of Transcranial Doppler ultrasound in the middle cerebral artery |
| Q42930744 | Response to letter regarding article, "Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the Third International Stroke Trial". |
| Q31107456 | Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis |
| Q57067266 | Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial |
| Q47547328 | Routinely collected data for randomized trials: promises, barriers, and implications |
| Q48240756 | Screening using whole-body magnetic resonance imaging scanning: who wants an incidentaloma? |
| Q48117345 | Shared decision making after severe stroke-How can we improve patient and family involvement in treatment decisions? |
| Q22306554 | Short term exposure to air pollution and stroke: systematic review and meta-analysis |
| Q57384721 | Spontaneous intracranial hypotension causing confusion and coma: a headache for the neurologist and the neurosurgeon |
| Q30585887 | Strokes: mimics and chameleons |
| Q30621033 | Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials |
| Q35599689 | Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials |
| Q34803876 | Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial |
| Q58857121 | The Brazilian Family Health Program and secondary stroke and myocardial infarction prevention: a 6-year cohort study |
| Q51787514 | The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. |
| Q51411516 | The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. |
| Q55512366 | The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England. |
| Q33162860 | The differential diagnosis of suspected stroke: a systematic review |
| Q46409018 | The risks and benefits of RTPA in acute ischemic stroke for patients at high risk of intracranial haemorrhage and poor functional outcome: a secondary analysis of the IST-3 trial and systematic review of prediction models. |
| Q48825158 | The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke |
| Q61911803 | Third International Stroke Trial |
| Q48741170 | Transient ischemic attack incidence in joinville, Brazil, 2010: a population-based study |
| Q56523451 | Treating anxiety after stroke (TASK): the feasibility phase of a novel web-enabled randomised controlled trial |
| Q61911805 | Uncertainties About Thrombolysis for Stroke Should Be Addressed With Large-Scale Randomized Trials |
Search more.